Neoadjuvant treatment for gastric cancer.

Neoadjuvant treatment for gastric cancer.

Item
http://www.wikidata.org/entity/Q36993475
Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.Incidence of microscopically positive proximal margins in adenocarcinoma of the gastroesophageal junction.Gastric cancer and the epoch of immunotherapy approachesContribution of diffusion weighted MRI to diagnosis and staging in gastric tumors and comparison with multi-detector computed tomography.Prospective comparison of 3T MRI with diffusion-weighted imaging and MDCT for the preoperative TNM staging of gastric cancer.Capecitabine plus paclitaxel induction treatment in gastric cancer patients with liver metastasis: a prospective, uncontrolled, open-label Phase II clinical study.Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysisBlood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4.Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.
P2860

Neoadjuvant treatment for gastric cancer.

Item
http://www.wikidata.org/entity/Q36993475
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Neoadjuvant treatment for gastric cancer.
@en
type
label
Neoadjuvant treatment for gastric cancer.
@en
prefLabel
Neoadjuvant treatment for gastric cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Neoadjuvant treatment for gastric cancer.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932